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Abstract 
Background: Heterologous expression systems based on promoters inducible with isopropyl-β-D-1-
thiogalactopyranoside (IPTG), e.g., Escherichia coli BL21(DE3) and cognate LacIQ/PlacUV5-T7 vectors, are commonly used 
for production of recombinant proteins and metabolic pathways. The applicability of such cell factories is limited by 
the complex physiological burden imposed by overexpression of the exogenous genes during a bioprocess. This 
burden originates from a combination of stresses that may include competition for the expression machinery, side-
reactions due to the activity of the recombinant proteins, or the toxicity of their substrates, products and intermedi-
ates. However, the physiological impact of IPTG-induced conditional expression on the recombinant host under such 
harsh conditions is often overlooked.
Results: The physiological responses to IPTG of the E. coli BL21(DE3) strain and three different recombinants carrying 
a synthetic metabolic pathway for biodegradation of the toxic anthropogenic pollutant 1,2,3-trichloropropane (TCP) 
were investigated using plating, flow cytometry, and electron microscopy. Collected data revealed unexpected nega-
tive synergistic effect of inducer of the expression system and toxic substrate resulting in pronounced physiological 
stress. Replacing IPTG with the natural sugar effector lactose greatly reduced such stress, demonstrating that the 
effect was due to the original inducer’s chemical properties.
Conclusions: IPTG is not an innocuous inducer; instead, it exacerbates the toxicity of haloalkane substrate and 
causes appreciable damage to the E. coli BL21(DE3) host, which is already bearing a metabolic burden due to its con-
tent of plasmids carrying the genes of the synthetic metabolic pathway. The concentration of IPTG can be effectively 
tuned to mitigate this negative effect. Importantly, we show that induction with lactose, the natural inducer of Plac, 
dramatically lightens the burden without reducing the efficiency of the synthetic TCP degradation pathway. This sug-
gests that lactose may be a better inducer than IPTG for the expression of heterologous pathways in E. coli BL21(DE3).
Keywords: Metabolic burden, Substrate toxicity, Escherichia coli, Heterologous metabolic pathway, Isopropyl β-D-1-
thiogalactopyranoside, Lactose, 1,2,3-trichloropropane, Metabolic engineering
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Background
Escherichia coli is among the most widely used micro-
bial hosts in both fundamental and applied research [1]. 
E. coli strain BL21(DE3) carries an inducible T7 RNA 
polymerase-dependent expression system that allows for 
the simple manipulation and tuning of protein produc-
tion levels, and it has become a laboratory workhorse 
[1–4]. This strain carrying commercial pET vectors or 
their derivatives has been the host of choice in numerous 
studies on recombinant protein expression [5, 6]. More 
recently, it has found applications as a cell factory for 
heterologous expression of entire biochemical pathways 
Open Access
Microbial Cell Factories
*Correspondence:  jiri@chemi.muni.cz 
1 Loschmidt Laboratories, Department of Experimental Biology 
and Research Centre for Toxic Compounds in the Environment RECETOX, 
Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00 Brno, 
Czech Republic
Full list of author information is available at the end of the article
Page 2 of 15Dvorak et al. Microb Cell Fact  (2015) 14:201 
in the emerging fields of metabolic engineering and syn-
thetic biology [6–10].
Despite its popularity, the E. coli BL21(DE3) and 
LacIQ/PlacUV5-T7 expression system suffers from certain 
drawbacks that mainly stem from the rapid and strong 
overexpression of recombinant proteins triggered by 
exposure to the synthetic inducer IPTG. The negative 
effects on host fitness associated with redirecting cells’ 
metabolic capacities to achieve high levels of protein pro-
duction are known as the metabolic burden or metabolic 
load [11]. The burden is often attributed to the overcon-
sumption of metabolic precursors (e.g., amino acids, 
rRNAs, ATP, and reducing power) to fuel the synthesis 
of non-essential foreign proteins [12] or the energeti-
cally demanding maintenance and replication of plasmid 
vectors bearing heterologous genes and selection mark-
ers [13–15]. Fitness costs associated with the activities of 
the foreign proteins, which may cross-talk with the host’s 
extant metabolic network [11] and burdens linked to the 
components of the expression system, such as the IPTG 
inducer and its import into the cell, are also frequently 
discussed [16, 17].
In addition to metabolic burden originating from the 
expression of foreign pathway components, the microbial 
cell factories used for biosynthesis of value-added chemi-
cals or biodegradation of polluting compounds may be 
challenged by the toxicity of the processed substrate or its 
metabolic intermediates. These issues must be accounted 
for when considering the evolution of metabolic routes 
for biodegradation in natural and heterologous hosts 
[18–22]. Toxicity problems have also been encountered 
during the engineering of biosynthetic pathways for fatty 
acids, 1,3-propanediol, amorphadiene, taxadiene, and 
ethanol in E. coli [9, 23–27]. In addition, studies on the 
consolidated bioprocessing of lignocellulose have high-
lighted the potential adverse effects of inhibitory mole-
cules in biomass-hydrolysate substrates [28]. Our current 
understanding of cellular responses to the exogenous and 
endogenous stressors that may be encountered during 
bioprocesses is extensive [29]. However, the combined 
effects of multiple simultaneous stresses on the hosts and 
their engineered induction systems have not been exam-
ined in depth.
To address this knowledge gap, we examined a recom-
binant strain of E. coli BL21(DE3) under conditions 
that provide an extreme combination of exogenous and 
endogenous stresses. The studied strain bears foreign 
genes encoding a five-step synthetic metabolic pathway 
for converting the industrial waste product and emerg-
ing environmental pollutant 1,2,3-trichloropropane 
(TCP) into the commodity chemical glycerol (Scheme 1). 
We have previously assembled this pathway in E. coli 
BL21(DE3) under the control of the LacIQ/PlacUV5-T7 
system, and used the resulting construct to investigate 
reported pathway bottlenecks observed in  vivo in the 



































Scheme 1 Five-step biotransformation of 1,2,3-trichloropropane into glycerol by the enzymes of the synthetic biodegradation pathway. The path-
way consists of haloalkane dehalogenase DhaA from Rhodococcus rhodochrous NCIMB 13064 [33] with the haloalcohol dehalogenase HheC and 
epoxide hydrolase EchA from Agrobacterium radiobacter AD1 [34, 35]. Computer-assisted protein engineering was used to improve activity of the 
haloalkane dehalogenase towards 1,2,3-trichloropropane, leading to the development of the 32-fold more active and 26-fold more efficient mutant 
DhaA31 [31]. Formed glycerol can be utilized in central catabolic pathways of the host cell
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AD1 and in vitro in a version of the pathway constructed 
using immobilized enzymes [20, 22, 30]. By using protein 
engineering, metabolic engineering, and synthetic biol-
ogy techniques, we were able to improve the pathway’s 
performance [22, 31, 32] and identify two important fac-
tors limiting its output: an imbalance in the enantiose-
lectivity of the pathway’s enzymes, and the toxicity of 
the substrate and various pathway intermediates, which 
reduced the fitness of E. coli constructs incubated with 
TCP [20, 22].
Here, we assess the physiological consequences of 
using the IPTG-inducible system for the heterologous 
expression of this TCP degradation pathway. Our results 
demonstrate a negative synergistic effect of the inducer 
IPTG and the substrate TCP. Toxicity of TCP in resting 
E. coli BL21(DE3) cells is greatly exacerbated by pre-
induction with IPTG. This effect was observed in the 
cells affected by metabolic burden from correspond-
ing plasmids. Compared to this exacerbation effect, the 
physiological burden due to the production and presence 
of the pathway enzymes was minor. Moreover, we show 
that it is possible to moderate the pathway’s fitness cost 
by tuning the IPTG concentration or reduce it dramati-
cally by replacing IPTG with the natural inducer lactose. 
These findings highlight the need to take great care when 
selecting inducible systems for heterologous expression 
of metabolic pathways that catalyse harsh reactions, and 
to finely tune the fitness-productivity trade-off by opti-
mizing the identity and concentration of the inducer.
Results and discussion
Biotransformation of TCP by resting E. coli BL21(DE3) cells 
carrying variants of a synthetic degradation pathway
Variants of the synthetic pathway featuring either the 
wild-type haloalkane dehalogenase or the 26-fold cata-
lytically more efficient mutant DhaA31 were introduced 
into E. coli BL21(DE3) [22]. This host was selected 
because neither the enzymes nor the metabolites of the 
TCP pathway occur naturally in its metabolic network 
and because of the broad repertoire of commercially 
available Duet vectors for this strain, which enable the 
tunable co-expression of multiple genes in a single cell 
[5]. This resulted in the construction of a flexible system 
with limited risk of metabolic cross-talk, in which the 
expression of the three pathway components could be 
manipulated orthogonally [22, 32]. Three previously con-
structed E. coli BL21(DE3) degraders designated degWT, 
deg31, and deg31opt were tested (Table 1). E. coli degWT 
carries a variant of the TCP pathway based on the wild-
type DhaA together with HheC and EchA, expressed in a 
relative ratio of 0.24:0.36:0.40, respectively, as determined 
after pre-induction with 0.2 mM IPTG (Additional file 1: 
Fig. S1). Strains deg31 and deg31opt both carry the TCP 
pathway featuring the engineered dehalogenase DhaA31, 
Table 1 Bacterial strains and plasmids used in this study
a Antibiotic markers: Sm streptomycin, Amp ampicillin, Cm chloramphenicol
Plasmid or strain Relevant characteristicsa Source or reference
Plasmids
 pCDFDuet-1 Expression vector; CDF (pCloDF13 replicon), encodes two multiple cloning sites, each of which is 
preceded by a T7 promoter, a lac operator, and a ribosome binding site; SmR
Merck Millipore, Germany
 pCDF-dhaAwt pCDFDuet-1 carrying wild-type dhaA gene (encoding haloalkane dehalogenase) from Rhodococcus 
rhodochrous NCIMB 13064
[22]
 pCDF-dhaA31 pCDFDuet-1 carrying mutant variant (dhaA31) of haloalkane dehalogenase gene [22]
 pETDuet-1 Expression vector; ColE1 (pBR322 replicon), encodes two multiple cloning sites, each of which is pre-
ceded by a T7 promoter, a lac operator, and a ribosome binding site; AmpR
Merck Millipore, Germany
 pETDuet-echA-hheC pETDuet-1 carrying wild-type echA and hheC genes (encoding epoxide hydrolase and haloalcohol 
dehalogenase) from Agrobacterium radiobacter AD1
[22]
 pACYCDuet-1 Expression vector; P15A (pACYC184 replicon), encodes two multiple cloning sites, each of which is 
preceded by a T7 promoter, a lac operator, and a ribosome binding site; CmR
Merck Millipore, Germany
 pACYC-echA-hheC pACYC-1 carrying the wild-type echA and hheC genes (encoding epoxide hydrolase and haloalcohol 
dehalogenase) from Agrobacterium radiobacter AD1
[22]
Escherichia coli
 DH5α Cloning host; Φ80lacZΔM15 recA1 endA1 gyrA96 thi-1 hsdR17(rK
−mK
+) supE44 relA1 deoR Δ(lacZYA-
argF)U169
Life Technologies, USA
 BL21(DE3) Expression host; F− ompT gal dcm lon hsdSB(rB
− mB
−) λ(DE3 [lacIQ lacUV5-T7 gene 1 ind1 sam7 nin5]) Life Technologies, USA
 Host control E. coli BL21(DE3) transformed with pCDF and pETDuet, control strain with empty plasmids This study
 degWT E. coli BL21(DE3) transformed with pCDF-dhaAwt and pETDuet-echA-hheC [22]
 deg31 E. coli BL21(DE3) transformed with pCDF-dhaA31 and pETDuet-echA-hheC [22]
 deg31opt E. coli BL21(DE3) transformed with pCDF-dhaA31 and pACYC-echA-hheC [22]
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but the relative ratio of the three enzymes in deg31 is 
0.14:0.41:0.45 while in deg31opt it is 0.63:0.16:0.21. 
Sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS-PAGE) experiments indicated that the three 
pathway enzymes together accounted for a similar pro-
portion of the total soluble protein fraction produced by 
all three degraders: 52 % for degWT, 54 % for deg31, and 
44 % for deg31opt.
Pre-induced (0.2 mM IPTG) resting cells of each of the 
recombinant strains and a host control (Table  1) were 
incubated in phosphate buffer with 2  mM TCP, and the 
time-courses of TCP biotransformation over a 5 h inter-
val were recorded (Fig. 1). The reaction profiles revealed 
fundamental differences between the strains with respect 
to the initial rates of TCP dehalogenation, accumulation 
of intermediates, and overall efficiency of glycerol forma-
tion. The theoretical concentrations of glycerol, otherwise 
rapidly utilized by E. coli, could be calculated from the 
experimental concentrations of TCP and detected inter-
mediates by virtue of the pathway’s orthogonal nature [22, 
32]. While deg31opt benefited from the fastest first step 
(Fig. 1d), the best balanced pathway with the highest glyc-
erol production was deg31 (Fig.  1c). On the other hand, 
degWT suffered from slow TCP conversion (Fig. 1b), pro-
longed exposure to the toxic substrate, and insufficient 
pathway output. As expected, the host control (carrying 
the corresponding empty plasmids, Fig.  1a) showed no 
activity toward TCP in the closed batch system.
The three E. coli recombinants and the control strain 
lacking the synthetic route represent a suitable model 
system for studying the contribution of metabolic burden 
and substrate/metabolite toxicity to the fitness cost of 
TCP biotransformation by whole-cell catalysts.
Assessment of metabolic burden and substrate toxicity 
effects by plating
Cell viability, estimated by plating, is a key physiological 
parameter that should reflect the individual strains’ abil-
ity to cope with the stresses caused by the metabolic bur-
den and TCP exposure [36]. E. coli degraders pre-induced 
with 0.2 mM IPTG and host controls were plated before 
and after 5  h of incubation in phosphate buffer with or 
without 2 mM TCP. The percentage of surviving cells was 
calculated after incubation.
The data obtained from plating before incubation 
(Fig.  2a) illustrate the separate effects of individual ele-
ments of the overall metabolic burden imposed on the 
cells. Several factors, including the presence of plasmid 
DNA and the associated selection markers, the addition 
of IPTG, and the burden due to heterologous pathway 
expression affected the degraders’ viability in parallel 
even before the addition of the toxic substrate. The most 
pronounced impact at this stage was due to plasmid 
maintenance and the associated constitutive expression 
of selection marker genes from the Duet vectors, as well 
as the presence of IPTG. The presence of two medium-
to-high copy plasmids pCDF (20–40 copies per cell) and 
pETDuet (~40 copies per cell) reduced viability by 50 % 
(P  <  0.01; Fig.  2a). The “pre-induction” of the host con-
trol with empty plasmids reduced viability by almost 
40 % relative to the non-induced control (P < 0.01). The 
expression of pathway enzymes in the E. coli degraders 
further reduced viability by about 20 % (P < 0.05). Addi-
tional reduction of viability of deg31opt compared to 
degWT and deg31 can be potentially attributed to the 
difference in antibiotic selection markers among three 
recombinants.
The data collected after 5 h incubation with or without 
TCP (Fig. 2b and Additional file 1: Fig. S2) included sev-
eral unexpected observations. Surprisingly, TCP (initially 
added at a concentration of 2  mM) had only minor or 
negligible effects on the viability of non-induced control 
cells bearing empty plasmids; there was no significant 
difference in viability between these cells and the host 
controls that were exposed to neither TCP nor IPTG. 
This was unexpected because TCP has been reported 
to strongly inhibit growing cells of E. coli BL21(DE3) 
and natural hosts such as A. radiobacter AD1 or Pseu-
domonas putida MC4 even at concentrations 50 % lower 
than those used here [20, 22, 37]. On the other hand, the 
detrimental effect of IPTG was statistically significant 
(P < 0.01) (Fig. 2b and Additional file 1: Fig. S2). The most 
striking observation was that the relative viability of cells 
pre-induced with IPTG and then exposed to TCP was 
almost 90  % lower than that of host controls exposed 
to neither substance (P  <  0.01) (Fig.  2b). This dramatic 
loss of viability does not correspond to a simple sum of 
the two compounds’ individual effects; it is obvious that 
the IPTG exacerbated the toxicity of TCP. The fact that 
IPTG exacerbated the toxicity of TCP and not vice versa 
was confirmed by plating of three recombinants bearing 
the synthetic biodegradation pathway (Fig. 2b). Because 
these degraders had functional pathways for TCP deg-
radation, they were better able to tolerate its presence. 
Importantly, the faster the conversion of TCP by the 
pathway enzymes, the greater the degraders’ viability. 
Deg31opt, which achieved a rapid initial conversion of 
TCP but accumulated significant quantities of the inter-
mediates DCP and GDL, survived the 5  h incubation 
almost as well as the host control that was not exposed 
to the substrate. These data are consistent with the pre-
viously reported results of growth arrest tests, which 
indicated that TCP is the most toxic compound in the 
pathway [22].
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Assessment of metabolic burden and substrate toxicity 
effects by multi‑parameter flow cytometry
Multi-parameter flow cytometry allows simultaneous 
determination of several biochemical and physical vari-
ables immediately after sample preparation and hence 
should provide more accurate information on the cells’ 
physiological status than can be obtained by plating [38, 
39]. This technique also offers key information on the 
heterogeneity of bacterial populations. Unlike plating, 
it does not underestimate the number of viable cells in 
original cultures in cases when a fraction of the popula-
tion has experienced sublethal injury and lost the capac-
ity to grow [39, 40].
Incubation of the three degraders and host controls was 
conducted under the conditions mentioned in the previ-
ous section. The samples withdrawn after 5 h incubation 
Fig. 1 Biotransformation of TCP catalysed by different Escherichia coli BL21(DE3) recombinants. a Control strain carrying the empty pCDF and 
pETDuet plasmids with streptomycin and ampicillin resistance marker genes, respectively. The blue arrows indicate individual T7 promoters. b The 
degrader degWT, which carries the haloalkane dehalogenase gene (dhaA) on pCDF and the haloalcohol dehalogenase (hheC) and epoxide hydro-
lase (echA) genes on pETDuet. c The degrader deg31, which carries the haloalkane dehalogenase mutant (dhaA31) gene on pCDF and two remain-
ing genes of the degradation pathway on pETDuet. d The degrader deg31opt, which carries the dhaA31 gene on pCDF and the two remaining 
genes of the degradation pathway on pACYC along with a chloramphenicol marker gene. The relative ratios of the TCP pathway genes produced 
by the degraders degWT, deg31, and deg31opt are 0.24:0.36:0.40, 0.14:0.41:0.45 and 0.63:0.16:0.21, respectively; the corresponding theoretical 
conversions of TCP into glycerol (GLY) are 35, 68, and 44 %, respectively. Error bars represent standard deviations calculated from three independ-
ent experiments. Theoretical concentrations of GLY were calculated from experimentally determined concentrations of TCP and intermediates. SmR 
streptomycin marker gene; AmpR ampicillin marker gene; CmR chloramphenicol marker gene; DCP 2,3-dichloropropan-1-ol; ECH epichlorohydrin; 
CPD 3-chloropropane-1,2-diol; GDL glycidol. Note that the green line representing ECH is not visible because this intermediate does not accumulate 
at detectable levels during the experiment
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with or without TCP were stained with propidium iodide 
(PI), 6-carboxy-2′,7′-dichlorodihydrofluorescein diac-
etate (carboxy-H2DCFDA), or bis-(1,3-dibutylbarbi-
turic acid) trimethine oxonol [DiBAC4(3)]. Dyes for 
labelling of nucleic acids, such as PI, which only enters 
cells with compromised membranes, are commonly 
used with membrane potential-sensitive dyes such as 
DiBAC4(3), which binds the lipid-containing intracellular 
components, to study bacterial viability [38, 39, 41]. Car-
boxy-H2DCFDA is a chemically reduced, acetylated and 
carboxylated form of fluorescein that has found many 
applications as a general indicator for the presence of 
reactive oxygen species (ROS) in eukaryotic and prokar-
yotic cells [42]. Recent studies on bacterial utilization 
of chlorinated aliphatic hydrocarbons suggest that this 
process is associated with strong oxidative stress and we 
Fig. 2 Effects of metabolic burden and TCP toxicity on physiological parameters of Escherichia coli BL21(DE3) cells and three recombinants 
expressing the synthetic metabolic pathway. a Viability of cells non-induced or pre-induced with IPTG determined by plating before incubation in 
phosphate buffer. The effects of metabolic burden stemming from the presence of plasmids, pre-induction with 0.2 mM IPTG, and expression of the 
synthetic pathway are indicated by coloured arrows. Asterisks denote significance in decrease of cell count caused by each of three effects at either 
P < 0.05 (*) or P < 0.01 (**) when compared with preceding condition. b The percentage of surviving cells (upper graph) and the corresponding 
physiological parameters determined by flow cytometry (lower graph) after incubation in buffer with or without 2 mM TCP. The separate effects of 
TCP, IPTG, and the exacerbation of TCP toxicity in cells pre-induced with IPTG are indicated by coloured arrows. Asterisks denote significant difference 
in the decrease of cell count caused by each of three effects at P < 0.01 when compared with preceding condition. Physiological parameters includ-
ing membrane permeability, formation of reactive oxygen species (ROS), and membrane depolarization were evaluated by staining the cells with 
appropriate dyes as explained in the Methods section. Error bars represent standard deviations calculated from at least five independent experi-
ments. CFU colony forming units; host-p E. coli BL21(DE3) without plasmids; host E. coli BL21(DE3) with the empty pETDuet and pCDF plasmids
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hypothesized that TCP would also evoke such a physi-
ological response [42, 43]. The saturation of unsaturated 
fatty acids by halogenation or lipid peroxidation causes 
changes in membrane fluidity, resulting in the collapse of 
electron transport chains and premature electron trans-
fer to oxygen, accompanied by ROS formation, mem-
brane permeabilization, and cell death [44, 45].
The end-point flow cytometry protocol adopted in 
our study was less sensitive than plating in demonstrat-
ing the burden caused by plasmids (Fig.  2b), possibly 
because the presence of heterologous DNA and the con-
stitutive expression of selection markers did not directly 
alter properties targeted by cytometry but instead imbal-
anced the cells’ overall energy status. However, the flow 
cytometry approach using selected fluorochromes was 
useful in exposing the toxic effects of IPTG and TCP. 
There were no significant differences (P > 0.05) between 
the non-induced host controls with empty plasmids, 
regardless of their TCP exposure status, with respect to 
any of the three variables examined in these experiments 
(membrane permeability, ROS formation, and membrane 
potential; see Fig.  2b). However, the proportion of cells 
staining positive for DiBAC4(3) increased up to threefold 
in the control treated with IPTG alone (P  <  0.01). The 
same effect was also observed in deg31, whose response 
to induction and incubation with TCP was studied in 
more detail (Fig.  3). The fraction of the bacterial popu-
lation staining positively with all three dyes increased 
many-fold when pre-treatment with IPTG was combined 
with TCP exposure, confirming the previously observed 
exacerbating effect and indicating that the action of 
TCP in bacterial cells is accompanied by extensive ROS 
Fig. 3 Transmission electron microscopy of Escherichia coli deg31 cells and corresponding histograms showing the physiological state of popula-
tions stained with selected fluorescent dyes. a Non-induced cells incubated in phosphate buffer. b Non-induced cells incubated in phosphate 
buffer with 2 mM TCP. c Cells pre-induced with 0.2 mM IPTG incubated in phosphate buffer. d Cells pre-induced with 0.2 mM IPTG and incubated in 
phosphate buffer with 2 mM TCP. Black arrows indicate bodies that presumably consist of overexpressed heterologous proteins, grey arrows indicate 
separations of the inner and outer cell membranes, and white arrows indicate dead or dying cells
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formation (Figs.  2b, 3). Membrane depolarization, ROS 
accumulation, and membrane permeability were reduced 
in E. coli recombinants expressing the synthetic biodeg-
radation pathway, with the degree of reduction being 
proportional to the strains’ initial rates of TCP conver-
sion. Interestingly, the exacerbation of compound toxic-
ity by pre-induction of the BL21(DE3) host control with 
IPTG was confirmed also in experiments using the model 
toxic compound tert-butyl hydroperoxide (TBHP), an 
organic peroxide and strong ROS formation promoting 
oxidative agent (Additional file 1: Fig. S3). This suggests 
that described exacerbation phenomenon should not be 
restricted only to our model toxic chemical TCP.
Membrane depolarization and ROS formation in  vivo 
are dynamic processes. To follow their kinetics in E. coli 
degraders we also performed time-resolved measure-
ments (Additional file  1: Fig. S4). The number of cells 
stained by DiBAC4(3) and carboxy-H2DCFDA increased 
linearly over time in all of the stressed recombinants 
except for deg31. Interestingly, this degrader exhibited an 
initial burst of DiBAC4(3) and carboxy-H2DCFDA fluo-
rescence but these signals then plateaued or fell slightly. 
We assume that the characteristic profiles of DiBAC4(3) 
and carboxy-H2DCFDA fluorescence for deg31 are 
linked to its unique variant of the synthetic biodegrada-
tion pathway and the corresponding time-course of TCP 
biotransformation. In contrast to the other strains, TCP, 
2,3-dichloropropane-1-ol (DCP) and glycidol (GDL) 
were present at relatively high concentrations in the 
deg31 reaction mixture between minutes 50 and 100 of 
the measurement period. This may have caused syner-
gistic toxicity, increasing the number of cells with depo-
larized membranes and enhanced ROS formation. Such 
joint effects are common; they have been observed for 
organophosphate pesticides, fluorosurfactants, and heavy 
metals, among others [46–48]. Subsequent freezing or 
moderate fall in the intensity of the signals was attributed 
to the parallel removal of TCP and GDL and the produc-
tion of glycerol, which is known to be an efficient stress 
protectant in yeast and solvent-tolerant strains of E. coli 
[49, 50].
The variant of the synthetic pathway present in deg31 
seemed to provide the best compromise in terms of cop-
ing with toxicity while efficiently converting TCP into 
harmless glycerol and was therefore selected for further 
investigation.
Assesment of metabolic burden and substrate toxicity 
effects by electron microscopy
Metabolic burden and toxicity can cause changes in the 
morphology of bacterial hosts [11, 51]. We therefore used 
transmission electron microscopy to study the changes 
in morphology of induced and non-induced deg31 cells 
after 5 h incubation with or without 2 mM TCP (Fig. 3). 
Pictures of induced and non-induced E. coli host con-
trol cells with empty plasmids are shown in (Additional 
file  1: Fig. S5). Microscopic observations were followed 
by multi-parameter flow cytometry of deg31 cells stained 
with PI, carboxy-H2DCFDA, or DiBAC4(3).
Incubation of non-induced degraders with TCP pro-
duced only a small proportion of dead bacterial cells, 
and the morphology of cells treated in this way did not 
generally differ from that of cells unexposed to the toxic 
substrate (Fig. 3a, b). The proportion of cells stained by 
carboxy-H2DCFDA and PI increased moderately, but 
no effect on the membrane potential was observed. 
Pre-induced bacteria producing recombinant proteins 
intensively formed visible inclusion bodies and showed 
frequent separation of the cytoplasmic membrane from 
the outer membrane at the poles of the cell (Fig. 3c). Since 
the majority of the recombinant proteins obtained from 
cell lysates were soluble (data not shown), we believe that 
the observed bodies consisted of active enzymes.
The combination of pre-induction and incubation with 
TCP produced the most pronounced morphological 
changes and was accompanied by substantial increases 
in the number of cells staining positively for PI, carboxy-
H2DCFDA, and DiBAC4(3) (Fig. 3d). Numerous dead or 
dying cells with damaged cytoplasmic membranes and 
leaked contents were clearly visible. Even so, a significant 
portion of the population resisted the combined effects 
of IPTG and TCP over the 5 h treatment period. This was 
mainly due to the well-balanced synthetic pathway of 
deg31 and its fast conversion of TCP to glycerol. Bistabil-
ity is a common phenomenon and can be attributed to 
noise in the expression of the multigenic traits respon-
sible for toxicity tolerance and the graduated stress 
response in the bacterial population [29, 36, 52]. In sum-
mary, our microscopic observations of deg31 populations 
treated under four different conditions were consistent 
with previous results and supported the conclusion that 
pre-induction with IPTG exacerbates TCP toxicity.
Toxicity exacerbation effect rises in cells experiencing 
metabolic burden from plasmids
Given that both the E. coli degraders and the host con-
trols used in this work had to cope with the metabolic 
burden of the Duet plasmids and LacIQ/PlacUV5-T7 
expression system, we decided to include E. coli controls 
without these components in the following experiment. 
For this purpose, we used E. coli BL21(DE3) without 
plasmids and the cloning strain E. coli DH5α, which lacks 
both the LacIQ/PlacUV5-T7 expression system and the 
lac operon. By employing the plating and flow cytom-
etry protocols described above, we found that the exac-
erbation effect was modest or completely absent in both 
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strains (Additional file 1: Fig. S6A, B). This suggests that 
the double stress from IPTG and TCP is only manifested 
in strains carrying Duet plasmids and the corresponding 
expression system.
We presume that the studied recombinants could not 
efficiently suppress the double stress from IPTG and the 
toxic substrate due to the metabolic burden imposed by 
plasmids and the corresponding shortage of resources 
required for cell maintenance. It seems that the chemi-
cal structure of IPTG, its transport or presence inside 
the cell triggers physiological changes that facilitate the 
manifestation of TCP toxicity in E. coli BL21(DE3) cells 
with Duet plasmids.
Reducing metabolic burden and toxicity exacerbation 
by tuning IPTG concentration
Next, we attempted to reduce the burden imposed on 
E. coli recombinants by optimizing the concentration of 
IPTG. We looked for the lowest possible concentration 
of inducer that would minimize the fitness cost with-
out significantly compromising the system’s efficiency at 
degrading TCP. Deg31 cells were pre-induced with IPTG 
concentrations ranging from 0.01 to 1.00  mM and the 
resulting effects on cell viability and pathway efficiency 
were studied (Fig. 4; Additional file 1: Fig. S7).
E. coli BL21(DE3) with the empty pETDuet and pCDF 
plasmids was used as a control for plating to assess 
the burden imposed on the host by IPTG exposure in 
the absence of the heterologous pathway (Fig.  4). The 
viability of the pre-induced degrader and control was 
checked before and after 5 h of incubation in phosphate 
buffer with 2 mM TCP and compared to that of cells not 
exposed to IPTG (Fig.  4a, b). The percentage of surviv-
ing cells after incubation was calculated in each case 
(Fig.  4c). These experiments indicated that even in the 
absence of TCP there was an inverse correlation between 
the IPTG concentration and the viability of the recombi-
nant E. coli (Fig. 4a). The deg31 strain suffered more from 
increasing IPTG concentrations than the control, prob-
ably due to the additional burden of expressing genes 
encoding the synthetic pathway. The opposite was true 
after 5  h of incubation because the TCP-catabolizing 
deg31 strain was more resistant to exacerbated toxicity 
than the host control (Fig. 4b, c). The synthetic pathway 
strain exhibited similar survival rates at all tested IPTG 
concentrations except for the highest—the relative viabil-
ity of deg31 pre-induced with 1 mM IPTG was 100 %. We 
assumed that this outlying value was due to underestima-
tion of the number of viable cells before incubation due 
to the intensive stress experienced by the degrader upon 
induction with such a high concentration of IPTG and 
the resulting presence of viable-but-not-culturable cells 
in the suspension [40]. Plating experiments demonstrated 
that a fraction of the bacterial population regained its 
capacity to grow and reproduce some time after treat-
ment with this high concentration of IPTG (Additional 
file 1: Fig. S8).
The time-courses of TCP biotransformation with rest-
ing cells of deg31 pre-induced with IPTG at 1.00, 0.20, 
0.05, 0.025, and 0.01 mM (Additional file 1: Fig. S7) and 
densitometric analysis of SDS polyacrylamide gels with 
the corresponding samples of cell-free extracts (Addi-
tional file 1: Fig. S9, Table S1) showed that: (i) the relative 
ratio of pathway enzymes and the shape of the degrada-
tion profile did not change substantially with the inducer 
concentration, while (ii) the content of the three pathway 
enzymes in the total soluble protein of the recombinant 
Fig. 4 Viability of Escherichia coli deg31 and host control strains after 
pre-induction with diverse concentrations of IPTG or 1 mM lactose, 
before and after incubation with TCP. a Viability of deg31 and E. coli 
BL21(DE3) with the empty pETDuet and pCDF plasmids as deter-
mined by plating of cells pre-induced with different concentrations 
of IPTG or 1 mM lactose (red columns) before incubation in phosphate 
buffer with TCP. b Viability of cells after incubation in buffer with 
2 mM TCP. Asterisks denote significantly higher (at P < 0.05) cell count 
of deg31 pre-induced with 1 mM lactose when compared with the 
count of cells pre-induced with the lowest tested concentration of 
IPTG (0.01 mM). c Fraction of surviving cells calculated as the differ-
ence in the CFUs.ml−1.OD−1600 before and after incubation with TCP. 
Error bars represent standard deviations calculated from at least four 
independent experiments. CFU colony forming units
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bacteria decreased from 55  % (1  mM IPTG) to 32  % 
(0.01  mM IPTG) and the pathway’s output decreased 
from 70 to 46 %. Appreciable conversion of TCP was also 
achieved with non-induced cells due to the leakiness of 
the T7 promoter and basal expression of genes within the 
pathway (Additional file 1: Fig. S7).
Figure  5 summarizes the balance of the three param-
eters discussed in the preceding sections: (i) host viabil-
ity, (ii) the cellular expression of pathway enzymes, and 
(iii) the output of the synthetic biodegradation route. 
We conclude that the minimal IPTG concentration that 
allows sufficient expression of genes within the path-
way to achieve a reasonable output is 0.025 mM. Similar 
inducer concentrations that allow full gene expression 
have been reported for single recombinant proteins such 
as β-galactosidase, green fluorescent protein, and rham-
nulose-1-phosphate aldolase [53–55]. Note that IPTG 
concentration of 0.025  mM is eight times lower than 
the originally tested inducer concentration and up to 
40-times lower than the values reported in the scientific 
literature describing engineering of heterologous path-
ways in E. coli [9, 56]. Induction with lower amounts of 
IPTG improved the host’s fitness. However, even the low-
est concentration of 0.01 mM reduced the viability of the 
E. coli degrader by 30  % relative to non-induced deg31, 
and by up to 50 % relative to the non-induced host con-
trol (P < 0.05 in both cases; Fig. 4b). We therefore inves-
tigated the scope for replacing IPTG with an alternative 
inducer.
Reducing metabolic burden and toxicity exacerbation 
by inducing with lactose
Lactose is a natural inducer of the lac operon and can 
be employed as a cheaper alternative to synthetic IPTG. 
It has been proven to induce expression of recombinant 
proteins in E. coli to the same extent as IPTG on both 
laboratory and industrial scales [12, 57, 58]. In contrast to 
IPTG, lactose is a substrate of β-galactosidase (encoded 
by lacZ) and thus can be metabolized by cells with an 
intact lac operon, including E. coli BL21(DE3). Therefore, 
concentrations of lactose up to 30  mM are commonly 
used to induce the expression of cloned genes at levels 
that can be achieved with ≤1 mM IPTG [58].
We investigated the pre-induction of deg31 cells with 
1  mM lactose. We assumed that this concentration 
would be sufficient to induce the expression of the TCP 
degradation pathway genes at levels that would confer 
adequate degradation efficiency. This expectation was 
confirmed by recorded time-courses of TCP biotransfor-
mation and the finding that pathway enzymes accounted 
for up to 41  % of the cells’ total soluble protein under 
these conditions (Additional file  1: Figs. S7 and S9, and 
Table S1). The theoretical conversion of TCP into glycerol 
under these conditions was 63 %. These values are close 
to those observed for deg31 cells pre-induced with 0.025 
or 0.05 mM IPTG. Most importantly, the deg31 cells pre-
induced with lactose exhibited higher viability before 
and after 5  h incubation with TCP compared to bacte-
ria treated with IPTG at any of the concentrations tested 
(P < 0.05; Fig. 4). The same relieving effect was observed 
for the host control. In term of survival, the cells pre-
induced with lactose performed almost as well as their 
non-induced counterparts (Fig. 4c). In keeping with the 
plating results, flow cytometric analysis of host control 
and deg31 cells pre-induced with lactose revealed sig-
nificantly lower levels of stressed cells with depolarized 
membranes than were observed for E. coli strains pre-
induced with IPTG (P < 0.01; Additional file 1: Fig. S10). 
These results indicated again that the action of IPTG in 
the studied recombinants was consistently accompanied 
by changes in membrane properties.
A higher viability of cells induced with lactose instead 
of IPTG was previously reported for the expression of 
single heterologous proteins [12, 56, 58]. This effect was 
attributed to the delayed, milder induction achieved 
with the natural inducer. In contrast to synthetic IPTG, 
which can enter the cell rapidly both by passive diffu-
sion and with the help of the LacY lactose permease, 
lactose can only enter the cytoplasm via the permease. 
Moreover, lactose must be converted into allolactose 
by β-galactosidase before binding to the lac repres-
sor whereas IPTG binds to the repressor directly. Our 
results confirm that lactose imposes a lower metabolic 
Fig. 5 Summarized effects of IPTG concentration on gene expression 
levels, pathway output, and cell viability in pre-induced Escherichia 
coli deg31 cells. Viability was determined by plating pre-induced 
deg31 cells resuspended in phosphate buffer before incubation with 
TCP. Pathway output was expressed as the theoretical conversion of 
TCP into glycerol at the end of 5 h degradation experiments with 
pre-induced, resting deg31 cells (see also Additional file 1: Fig. S5). 
The content of TCP pathway enzymes was estimated by analyzing 
cell-free extracts obtained from pre-induced cells by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (Additional file 1: Fig. S7 
and Table S1). Two gels were analysed by densitometry and mean 
values are shown. Error bars represent standard deviations calculated 
from three independent experiments. Values determined for deg31 
pre-induced with 1 mM lactose are indicated by squares
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burden than IPTG, suggesting that it is also a more suit-
able inducer for the expression of entire heterologous 
pathways in E. coli BL21(DE3). This is particularly impor-
tant for E. coli BL21(DE3) cells carrying synthetic path-
ways that degrade toxic compounds or produce toxic 
intermediates.
Conclusions
We studied the toxicity of TCP and its derived metabo-
lites in E. coli BL21(DE3) carrying an inducible synthetic 
metabolic pathway comprising three catabolic genes 
[22]. The presence of plasmid DNA, exposure to IPTG, 
and the metabolic burden of the heterologous pathway 
were shown to affect the viability of E. coli degraders 
even before contact with the toxic substrate. The most 
pronounced impact was attributed to plasmid mainte-
nance: the presence of two medium-to-high copy num-
ber plasmids (pCDF and pETDuet) reduced cell viability 
by 50 %. Pre-induction of host control cells carrying the 
empty plasmids caused a 40  % decrease in viability, 
while expression of the genes within the pathway fur-
ther reduced viability by about 20  %. Treatment with 
exogenous TCP at a concentration of 2  mM had only a 
very minor or no effect on the viability of non-induced 
control cells carrying empty plasmids. The pronounced 
reduction in survival triggered by adding the substrate to 
pre-induced cells was unexpected, suggesting that TCP 
toxicity was exacerbated by pretreatment of the cells with 
IPTG. The recombinants clearly benefited from the pres-
ence of a functioning TCP degradation pathway—the 
faster the conversion of TCP, the greater the cell viability.
Flow cytometry with selected fluorochromes proved to 
be useful in dissecting the toxic effects of IPTG and TCP. 
Variations in the three monitored physiological param-
eters—membrane permeability, ROS formation, and 
membrane potential—was insignificant between the non-
induced host controls irrespective of exposure to TCP. 
The fraction of cells staining positively for individual 
dyes rose significantly when IPTG was added together 
with TCP, verifying the previously observed exacerbation 
effect and showing that TCP exposure causes intensive 
ROS formation in bacterial cells. All three parameters 
were reduced in E. coli BL21(DE3) recombinants express-
ing the synthetic biodegradation pathway, and the degree 
of reduction increased in parallel with the initial rate of 
TCP degradation. Cell counts and flow cytometry data 
were in good agreement with the results of electron 
microscopy experiments.
The potential toxicity of IPTG and its negative effect 
on cell growth has been repeatedly reported [9, 16, 60, 
61]. This effect was attributed to various factors includ-
ing the induced changes in the host metabolism [16], the 
active uptake of the inducer into the cell by LacY [17, 62], 
and the rapid induction of heterologous gene expres-
sion [12, 56, 59]. However, that widely used inducer can 
exacerbate the toxicity of another compound, leading 
to damage of host cells experiencing metabolic burden, 
has not been previously reported and should be of wide 
interest. E. coli BL21(DE3) or similar hosts with the DE3 
lysogen and well defined plasmid vectors are widely used 
because they make it possible to precisely balance the 
expression of heterologous pathway genes in metabolic 
engineering and synthetic biology [8, 10, 22, 25]. Still, 
insufficient attention has been paid to the possible exac-
erbation of multiple endogenous and exogenous stress-
ors that impose a complex burden on such cell factories. 
IPTG is often applied at sub-millimolar concentrations 
[9, 63, 64] although the amount needed for full induc-
tion of heterologous genes can be an order of magnitude 
lower. The optimal concentration of IPTG in any given 
case may be system-specific [56], but the relatively simple 
experiments can be used to guide the optimization of its 
concentration. Importantly, the use of lactose as an alter-
native inducer should be considered: we observed that 
replacing IPTG with lactose dramatically reduced the 
burden experienced by the transformed bacterial cells, 
suggesting that it may be a better inducer than IPTG 




TCP, DCP, epichlorohydrin (ECH), 3-chloropropane-
1,2-diol (CPD), GDL, and glycerol standards were pur-
chased from Sigma-Aldrich Co. (St. Louis, MO, USA). 
All chemicals used in this study were of analytical 
grade. The fluorescent indicators carboxy-H2DCFDA 
and DiBAC4(3) were purchased from Life Technologies 
Inc. (Waltham, MA, USA) and PI from Sigma-Aldrich 
Co. IPTG was purchased from Duchefa Biochemie B.V. 
(Haarlem, The Netherlands). Lactose and TBHP solu-
tion (5–6 M in decane) were from Sigma-Aldrich Co. A 
Free Glycerol Assay Kit was acquired from BioVision Inc. 
(Milpitas, CA, USA). LB medium (Sigma-Aldrich Co.) 
was used for routine cultivation of E. coli.
Bacterial strains and growth conditions
Plasmids and E. coli strains used in this study are sum-
marized in Table  1. E. coli DH5α was used as a control 
strain lacking lacZYA operon. E. coli BL21(DE3) was 
used as a heterologous host for inducible expression of 
the synthetic biodegradation pathway and also as a con-
trol strain bearing the lacZYA operon and LacIQ/PlacUV5-
T7 expression system. Three variants of the pathway were 
constructed previously in a modular way by combining 
genes encoding haloalkane dehalogenase DhaA from R. 
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rhodochrous NCIMB 13064, the DhaA mutant DhaA31, 
and genes encoding haloalcohol dehalogenase HheC and 
epoxide hydrolase EchA from A. radiobacter AD1 on 
Duet vectors [22]. For the purpose of this study, E. coli 
BL21(DE3) degraders and host control strain BL21(DE3) 
with empty pCDF and pETDuet plasmids were pre-
pared freshly by co-transforming plasmid constructs 
into competent cells using chemical transformation or 
electroporation. Cells were spread on LB agar plates with 
appropriate combination of antibiotics (25  μg.ml−1 Sm 
and 75  μg.ml−1 Amp for E. coli BL21(DE3) with empty 
pCDF and pETDuet, degWT, degWTopt, and deg31; 
25  μg.ml−1 Sm and 20  μg.ml−1 Cm for deg31opt) and 
grown overnight at 37  °C. A single colony was used for 
preparation of overnight cultures in 10 ml of LB medium 
with the corresponding antibiotics. Precultures (250  µl) 
were used to inoculate fresh LB medium (25  ml) and 
cultures were grown at 37  °C with shaking until the cell 
density reached an optical density measured at 600  nm 
(OD600) of 1 when the expression of recombinant genes 
was induced with IPTG or lactose. Induced cells were 
incubated overnight at 20  °C and biomass was collected 
at late exponential phase by centrifugation at 4000g for 
10  min (4  °C). Pellets were washed with ice-cold sterile 
filtered sodium phosphate buffer (50  mM, pH 7.0) and 
dissolved in the same buffer for further use.
Incubation of resting cells with TCP and assessment 
of viability by plating
Cell suspensions of pre-induced or non-induced E. coli 
degraders and host cell controls were diluted with ster-
ile filtered sodium phosphate buffer to a final OD600 of 
7.0. TCP (4 mM) was dissolved in 5 ml of the same buffer 
in glass vials (25 ml) with a screw cap mininert valve for 
1  h at 37  °C with shaking. The incubation was initiated 
by mixing 5 ml of the cell suspension with 5 ml of buffer 
with TCP. The final TCP concentration in 10 ml of the cell 
suspension of OD600 of 3.5 was 2 mM. In the cases indi-
cated, 1 mM TBHP was added instead of TCP. In case of 
E. coli degraders, cell suspension samples (0.5  ml) were 
quenched in 0.5 ml acetone with hexan-1-ol, vortexed for 
15 s and centrifuged at 18,000g for 2 min. The concentra-
tion of metabolites from the TCP pathway in the superna-
tant was analyzed using gas chromatography. The presence 
of GLY in the cell suspension was verified using a Free 
Glycerol Assay Kit (BioVision Inc.). Viability of degraders 
and controls before and after 2.5 or 5  h incubation with 
TCP was tested by plating 100 µl of cell suspension seri-
ally diluted with ice-cold sterile phosphate-buffered saline 
(PBS, 8 mM Na2HPO4, 1.5 mM KH2PO4, 3 mM KCl, and 
137  mM NaCl, pH =  7.0) onto Plate Count Agar plates. 
Plates were incubated for 24 h at 37 °C and grown colonies 
were counted as CFU.ml−1.OD−1600.
End‑point flow cytometry
At the end of incubation of E. coli degraders and host cell 
controls with or without TCP, 0.1 ml of each cell suspen-
sion was added to 0.9 ml of filtered PBS. The suspensions 
were added with carboxy-H2DCFDA (prepared as 4 mM 
stock solution in DMSO) to the final concentration of 
40 μM and with PI (prepared as 200 μg.ml−1 stock solu-
tion in PBS) to the final concentration of 2  μg.ml−1 or 
with 1 μM DiBAC4(3) (prepared as 25 μg.ml−1 stock solu-
tion in 4  mM EDTA). The suspensions with fluorescent 
probes were mixed by inverting and incubated in the dark 
for 10 min at room temperature. Flow cytometry analy-
sis of fluorescence levels was performed using BD FAC-
SAria II Sorp (BD Biosciences Co., San José, CA, USA) 
equipped with an argon-ion laser of 100 mW at 488 nm 
and a solid state 100 mW 561 nm as the excitation source. 
The carboxy-H2DCFDA or DiBAC4(3) fluorescence emis-
sion at 525 or 516  nm, respectively, was detected using 
a 525/50-nm band pass filter array. The PI fluorescence 
emission at 617  nm was detected using a 610/20-nm 
band pass filter array. Data for at least 50,000 cells per 
single sample per experiment were collected. Size-related 
forward scatter signals gathered by the cytometer were 
used by the Cyflogic 1.2.1 software (CyFlo Ltd., Finland) 
to gate fluorescence data from bacteria in the stream. 
Percentage of cells positive for carboxy-H2DCFDA, PI 
and DiBAC4(3) was calculated using the statistics module 
of the software.
Time‑resolved flow cytometry
For time-resolved measurements of ROS accumula-
tion in E. coli constructs, 0.5 ml of the cell suspension 
in sterile filtered sodium phosphate buffer (50 mM, pH 
7.0) of OD600 of 7.0 was added with carboxy-H2DCFDA 
at 40 μM. The suspension was mixed by inverting and 
incubated in the dark for 10 min at room temperature. 
The measurement was started immediately after mixing 
the cell suspension with 0.5  ml of sodium phosphate 
buffer with dissolved TCP in 5  ml polypropylene tube 
with snap cap. The final TCP concentration in 1 ml of 
cell suspension of OD600 of 3.5 was 2 mM. Flow cytom-
etry analysis of fluorescence levels in time was per-
formed on the same FACS instrumentation as above. 
FCS data were recorded in BD FACS Diva (v. 6.1.3, BD 
Biosciences Co.) at constant flow rate of 20,000 events.
s−1 for intervals of 5 s every 30 min for total period of 
5 h. Analysis of data was further performed in FlowJo 
LLC. (v. 7.6.5, Ashland, OR, USA) and exported to 
Excel (Office 2013, Microsoft Corp., Redmond, WA, 
USA) for graphical output. Time-resolved profiles of 
membrane depolarization in E. coli constructs during 
5 h incubation in phosphate buffer were compiled from 
end-point measurements performed at time 0, 1, 2, 3, 4, 
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and 5 h following the procedure described in previous 
section.
Determination of expression levels of the TCP pathway 
enzymes
The expression levels of DhaA31, HheC, and EchA were 
determined in E. coli constructs induced with diverse 
concentrations of IPTG or 1  mM lactose. Washed cells 
were resuspended in sodium phosphate buffer and cell 
density was adjusted to OD600 of 7.0. 1 U of DNaseI per 
1 ml of cell suspension was added. Cells were disrupted 
with One Shot cell disruptor (Constant Systems Ltd., 
UK) using 1.5 kbar shot. The cell lysate was centrifuged 
for 45 min at 18,000g at 4  °C and the resulting cell-free 
extract (CFE) was decanted. The concentration of total 
protein in CFEs was determined using Bradford reagent 
(Sigma Aldrich Co., USA). Samples of CFE containing 
5 μg of total protein were separated by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
CFE prepared from E. coli BL21 (DE3) cells without 
plasmids were used as controls. Gels were stained with 
Coomassie Brilliant Blue R-250 (Fluka/Sigma-Aldrich 
Co., Switzerland) and analyzed using a GS-800 Cali-
brated Imaging Densitometer (Bio-Rad Laboraories Inc., 
USA). The expression levels of DhaA31, HheC and EchA 
and the relative ratios of the enzymes in degWT, deg31, 
and deg31opt were estimated from trace densities of cor-
responding bands using the software Quantity One 4.6.9 
(Bio-Rad Laboratories Inc., USA).
Electron microscopy
To observe morphological changes, cells of E. coli deg31 
induced with 0.2  mM IPTG or non-induced were incu-
bated in presence or absence of 2  mM TCP in sodium 
phosphate buffer (50 mM, pH 7.0, OD600 of cell suspen-
sion of 3.5) at 37 °C for 5 h and then processed for trans-
mission electron microscopy. Briefly, cells were harvested 
and pelleted by centrifugation (5000g, 5  min). Pellets 
were washed and resuspended in phosphate buffer and 
fixed in 3  % glutaraldehyde solution in the same buffer 
for 1 h at room temperature. Cells were then post-fixed 
in 1  % osmium tetroxide in phosphate buffer and after 
addition of 2.5 % agar and dehydration in a graded series 
of ethanol, the blocks of cells were impregnated with 
Durcupan (Sigma-Aldrich Co., USA) and embedded in 
silicone embedding moulds. Polymerization occurred 
for 3 days at 60–80 °C. Ultrathin sections prepared with 
a diamond knife on an Ultramicrotome EM UC6 (Leica 
Microsystems GmbH, Germany) were placed on copper 
grids, stained with 2.5  % uranyl acetate for 10  min and 
Reynolds lead citrate solution for 3  min and observed 
with a Morgagni 268D (FEI Co., The Netherlands) trans-
mission electron microscope.
Gas chromatography and mass spectrometry 
measurements
A Gas Chromatograph 6890  N with a flame ionisation 
detector (GC-FID) and Gas Chromatograph 7890A and 
Mass Spectrometer (GC–MS) 5975C MSD (Agilent 
Technologies Inc., USA), both with the capillary column 
ZB-FFAP 30  m  ×  0.25  mm × 0.25  µm (Phenomenex 
Inc., USA) were used for routine analysis and quantifi-
cation of TCP and its metabolites or for verification of 
the presence of individual metabolites from the TCP 
pathway in selected samples, respectively. Samples (2 μl) 
were injected into the GC with an inlet temperature of 
250 °C and split ratio 20:1. The operational conditions for 
the column were: helium carrier gas with an initial flow 
of 0.6  ml.min−1 for 1  min, followed by a flow gradient 
from 0.6 to 1.8 ml.min−1 (ramp 0.2 ml.min−1), tempera-
ture program set to give an initial column temperature of 
50 °C for 1 min, followed by a temperature gradient from 
50 to 220 °C hold for 2 min (ramp 25 °C.min−1). The tem-
perature of the detector was 250 °C. MS scan speed was 
6.9  s−1. This method was used for all GC analyses. For 
that purpose, calibration curve of 0–5 mM of TCP, DCP, 
ECH, CPD and GDL with internal standard hexan-1-ol 
was prepared. Detection limits calculated using the soft-
ware OriginPro v8 (OriginLab Corporation, USA) were 3, 
5, 6, 186 and 22 μM for TCP, DCP, ECH, CPD and GDL, 
respectively.
Statistical analysis
All experiments were independently repeated at least 
three times (number of repetitions is specified in fig-
ure legends) and the mean value of the corresponding 
parameter  ±  standard deviation is presented. Statisti-
cal significance was assessed using Student’s t test with 
two-tailed hypothesis available in Microsoft Excel 2013 
(Microsoft Corp., USA). The difference in between two 
independent data sets was considered statistically signifi-
cant for P < 0.05.
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